Both mutations and the overexpression of beta-catenin are allied with different cancers, including ovarian and endometrial carcinomas, hepatocellular carcinoma, colorectal carcinoma, malignant breast tumors, and lung cancer [51]. The gene discussed is CTNNB1; the disease is lung carcinoma.